Literature DB >> 7809166

Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.

D C Foster1, C A Sprecher, F J Grant, J M Kramer, J L Kuijper, R D Holly, T E Whitmore, M D Heipel, L A Bell, A F Ching.   

Abstract

Thrombopoietin (TPO), a lineage-specific cytokine affecting the proliferation and maturation of megakaryocytes from committed progenitor cells, is believed to be the major physiological regulator of circulating platelet levels. Recently we have isolated a cDNA encoding a ligand for the murine c-mpl protooncogene and shown it to be TPO. By employing a murine cDNA probe, we have isolated a gene encoding human TPO from a human genomic library. The TPO locus spans over 6 kb and has a structure similar to that of the erythropoietin gene (EPO). Southern blot analysis of human genomic DNA reveals a hybridization pattern consistent with a single gene locus. The locus was mapped by in situ hybridization of metaphase chromosome preparations to chromosome 3q26-27, a site where a number of chromosomal abnormalities associated with thrombocythemia in cases of acute myeloid leukemia have been mapped. A human TPO cDNA was isolated by PCR from kidney mRNA. The cDNA encodes a protein with 80% identity to previously described murine TPO and is capable of initiating a proliferative signal to murine interleukin 3-dependent BaF3 cells expressing the murine or human TPO receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809166      PMCID: PMC45573          DOI: 10.1073/pnas.91.26.13023

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene.

Authors:  J D McDonald; F K Lin; E Goldwasser
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

2.  Speculations on RNA splicing.

Authors:  P A Sharp
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

3.  Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines.

Authors:  K Morishita; D S Parker; M L Mucenski; N A Jenkins; N G Copeland; J N Ihle
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

4.  Purification and properties of a megakaryocyte stimulatory factor present both in the serum-free conditioned medium of human embryonic kidney cells and in thrombocytopenic plasma.

Authors:  G Tayrien; R D Rosenberg
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

Review 5.  Thrombopoietin: its biology, purification, and characterization.

Authors:  T P McDonald
Journal:  Exp Hematol       Date:  1988-03       Impact factor: 3.084

6.  Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism.

Authors:  M L Law; G Y Cai; F K Lin; Q Wei; S Z Huang; J H Hartz; H Morse; C H Lin; C Jones; F T Kao
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia.

Authors:  R Bernstein; A Bagg; M Pinto; D Lewis; B Mendelow
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

8.  Propeptide of human protein C is necessary for gamma-carboxylation.

Authors:  D C Foster; M S Rudinski; B G Schach; K L Berkner; A A Kumar; F S Hagen; C A Sprecher; M Y Insley; E W Davie
Journal:  Biochemistry       Date:  1987-11-03       Impact factor: 3.162

9.  Murine erythropoietin gene: cloning, expression, and human gene homology.

Authors:  C B Shoemaker; L D Mitsock
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

10.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Authors:  D Pinkel; T Straume; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  15 in total

Review 1.  Chemoprotection of normal tissues by transfer of drug resistance genes.

Authors:  J A Rafferty; I Hickson; N Chinnasamy; L S Lashford; G P Margison; T M Dexter; L J Fairbairn
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

2.  Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.

Authors:  F Porteu; M C Rouyez; L Cocault; L Bénit; M Charon; F Picard; S Gisselbrecht; M Souyri; I Dusanter-Fourt
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.

Authors:  M Uchida; K Kirito; R Shimizu; Y Miura; K Ozawa; N Komatsu
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 4.  From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.

Authors:  Harinder Gill; Raymond S M Wong; Yok-Lam Kwong
Journal:  Ther Adv Hematol       Date:  2017-02-01

Review 5.  The biology of thrombopoietin and thrombopoietin receptor agonists.

Authors:  David J Kuter
Journal:  Int J Hematol       Date:  2013-07-03       Impact factor: 2.490

6.  Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in thrombopoietin.

Authors:  Aaron Seo; Miri Ben-Harosh; Mehtap Sirin; Jerry Stein; Orly Dgany; Joseph Kaplelushnik; Manfred Hoenig; Ulrich Pannicke; Myriam Lorenz; Klaus Schwarz; Clemens Stockklausner; Tom Walsh; Suleyman Gulsuner; Ming K Lee; Anoop Sendamarai; Marilyn Sanchez-Bonilla; Mary-Claire King; Holger Cario; Andreas E Kulozik; Klaus-Michael Debatin; Ansgar Schulz; Hannah Tamary; Akiko Shimamura
Journal:  Blood       Date:  2017-05-30       Impact factor: 22.113

7.  Functional and structural profiling of the human thrombopoietin gene promoter.

Authors:  Corinna Dördelmann; Ralph Telgmann; Eva Brand; Claudia Hagedorn; Bianca Schröer; Sandra Hasenkamp; Peter Baumgart; Peter Kleine-Katthöfer; Martin Paul; Stefan-Martin Brand-Herrmann
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

Review 8.  Eltrombopag for use in children with immune thrombocytopenia.

Authors:  Taylor Olmsted Kim; Jenny Despotovic; Michele P Lambert
Journal:  Blood Adv       Date:  2018-02-27

Review 9.  Pathologic thrombopoiesis of rheumatoid arthritis.

Authors:  Ihsan Ertenli; Sedat Kiraz; M Akif Oztürk; Ibrahim c Haznedaroğlu; Ismail Celik; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2003-02-11       Impact factor: 2.631

Review 10.  Clinical indications for thrombopoietin and thrombopoietin-receptor agonists.

Authors:  Bernhard Wörmann
Journal:  Transfus Med Hemother       Date:  2013-09-11       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.